ACOR
- NASDAQ - Medical-Biomed/Biotech
Acorda Therapeutics Inc
|
$38.04 |
-1.05 -2.67%
|
$39.62
|
$40.87
|
-6.92% |
383,755 74.95%
|
512,000
|
Most Recent Note for ACOR - 3/26/2014 12:17:40 PM
Perched within close striking distance of its 52-week high. Reported earnings +33% on +14% sales revenues for the Dec '13 quarter. Prior quarterly and annual earnings history (C and A criteria) has not been strong and steady.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AGN
- NYSE - DRUGS - Drug Manufacturers - Other
Allergan Inc
|
$122.85 |
-1.72 -1.38%
|
$125.13
|
$132.04
|
-6.96% |
3,121,459 118.24%
|
2,640,000
|
Most Recent Note for AGN - 3/26/2014 12:19:41 PM
Quarterly reports through Dec '13 showed sub par earnings increases. Its annual earnings growth has been steady. Retreated to its 50 DMA line abruptly after wedging to new 52-week highs with gains lacking great volume conviction. Prior mid-day reports cautioned - "Quarterly earnings comparisons have been below the +25% guideline. Rebounded to new highs after undercutting its 200 DMA line again during its latest consolidation since last noted in the 10/27/11 mid-day report."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ASRV
- NASDAQ - BANKING - Regional - Northeast Banks
Ameriserv Financial Inc
|
$3.82 |
+0.05
1.39%
|
$3.85
|
$3.92
|
-2.49% |
50,674 99.36%
|
51,000
|
Most Recent Note for ASRV - 3/26/2014 12:22:02 PM
The 3/24/14 mid-day report cautioned - "Quarterly and annual earnings history is not a match with the fact-based investment system's guidelines (C and A criteria). Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BEAV
- NASDAQ - AEROSPACE/DEFENSE - Aerospace/Defense Products & Services
B/E Aerospace Inc
|
$87.19 |
-0.73 -0.83%
|
$88.62
|
$88.75
|
-1.76% |
925,818 93.33%
|
992,000
|
Most Recent Note for BEAV - 3/26/2014 12:13:07 PM
Rebounded from its 200 DMA line to reach a new 52-week high since last noted with caution in the 1/13/14 mid-day report. Reported earnings +23% on +12% sales revenues for the Dec '13 quarter. Prior mid-day reports cautioned members - "Consecutive quarterly comparisons just below the +25% minimum earnings guideline (C criteria). A downturn in FY '09 earnings is a flaw with respect to the A criteria of the investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CBPO
- NASDAQ - DRUGS - Biotechnology
China Biologic Products
|
$35.46 |
+2.44
7.39%
|
$35.87
|
$38.60
|
-8.13% |
13,598 75.54%
|
18,000
|
Most Recent Note for CBPO - 3/26/2014 12:26:41 PM
Reported earnings +30% on +25% sale revenues for the Dec '13 quarter but fundamental concerns remain. Found support above prior highs and near its 50 DMA line since last noted in the 3/03/14 mid-day report, consolidating since spiking to new 52-week highs with volume-driven gains. Found support near its 200 DMA line after noted with caution in the 12/12/13 mid-day report - "Reported earnings +4% on +0% sales for the Sep 13 quarter, and earnings increases have been below the +25% minimum necessary to satisfy the C criteria. Waning annual earnings increases in FY '10 and '11 were noted as a flaw concerning the A criteria."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CSE
- NYSE - FINANCIAL SERVICES - Credit Services
Capitalsource Inc
|
$14.58 |
-0.11 -0.75%
|
$14.77
|
$15.47
|
-5.75% |
2,214,284 126.03%
|
1,757,000
|
Most Recent Note for CSE - 3/26/2014 12:28:07 PM
Stalled after reaching new 52-week high territory, and enduring distributional pressure. Consolidating near prior highs in the $15 area. Reported earnings +56% on +15% sales revenues for the Dec '13 quarter but fundamental concerns remain. Rebounded from below its 50 DMA line since noted with caution in the 2/13/14 mid-day report - "Earnings and sales revenues history is not a match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
FF
- NYSE - CHEMICALS - Specialty Chemicals
Futurefuel Corp
|
$20.52 |
-0.12 -0.58%
|
$20.89
|
$22.25
|
-7.78% |
155,764 68.62%
|
227,000
|
Most Recent Note for FF - 3/26/2014 12:33:03 PM
Hovering near its all-time high after an impressive spurt of volume-driven gains. Reported earnings +307% on +68% sales revenues for the Dec '13 quarter, but fundamental concerns remain. Prior high in the $19 area define support after its considerable "breakaway gap" on 3/18/14. Prior mid-day reports cautioned - "Reported greatly improved earnings in the Mar and Jun '13 quarters but with sub par sales revenues growth. Fundamental concerns remain with respect to the C and A criteria. Erratic sales revenues and earnings history is below the investment system guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
GIII
- NASDAQ - CONSUMER NON-DURABLES - Textile - Apparel Footwear
G Iii Apparel Group Inc
|
$70.86 |
-0.93 -1.30%
|
$72.29
|
$77.22
|
-8.24% |
185,688 63.59%
|
292,000
|
Most Recent Note for GIII - 3/26/2014 12:36:01 PM
Reported Jan '14 earnings and lowered guidance then gapped down on the prior session, abruptly retreating from its 52-week high. Finding support near its 50 DMA line after undercutting that important short-term average. The 1/29/14 mid-day report cautioned- " Found support at its 50 DMA line while making gradual progress. Reported earnings +19% on +23% sales revenues for the Oct '13 quarter and fundamental concerns remain. Earnings history has been erratic and below guidelines of the fact-based investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
KEY
- NYSE - BANKING - Money Center Banks
Keycorp
|
$14.32 |
-0.08 -0.58%
|
$14.50
|
$14.70
|
-2.61% |
8,057,973 67.71%
|
11,901,000
|
Most Recent Note for KEY - 3/26/2014 12:40:31 PM
Sales revenues have been waning and its quarterly and annual earnings history do not match with the C and A criteria. Recently rallied to a new 52-week high from an 8-week cup shaped base.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
LM
- NYSE - FINANCIAL SERVICES - Investment Brokerage - Regiona
Legg Mason Inc
|
$48.49 |
+2.04
4.39%
|
$48.52
|
$48.31
|
0.37% |
1,098,186 75.63%
|
1,452,000
|
Most Recent Note for LM - 3/26/2014 12:43:31 PM
Recently wedged higher and it is perched at its 52-week high. Earnings history is not a match with the fact-based investment system's guidelines. Last noted on 3/10/06 when dropped from the Featured Stocks list. First featured on 6/2/05 at $87.50.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
OZRK
- NASDAQ - BANKING - Regional - Southeast Banks
Bank Of The Ozarks Inc
|
$68.10 |
+0.96
1.43%
|
$68.47
|
$70.49
|
-3.39% |
144,817 64.94%
|
223,000
|
Most Recent Note for OZRK - 3/26/2014 12:46:13 PM
Extended from any sound base and making gradual progress since last noted in the 1/13/14 mid-day report with caution - "Recent quarterly comparisons through Dec '13 showed less than +25% earnings increases (C criteria) while sales revenues growth was not strong and consistent. Annual earnings (A criteria) has been mostly slow and steady."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SNAK
- NASDAQ - FOOD & BEVERAGE - Processed & Packaged Goods
Inventure Foods Inc
|
$14.29 |
+0.01
0.07%
|
$14.50
|
$14.38
|
-0.63% |
48,436 65.45%
|
74,000
|
Most Recent Note for SNAK - 3/26/2014 12:48:24 PM
Inching further into new high territory and making gradual progress above prior resistance in the $14 area after building a sound base. Prior mid-day reports cautioned members - "Reported earnings +75% on +35% sales revenues for the Dec '13 quarter but fundamental concerns remain. Earnings history is not a match with the fact-based investment system's guidelines (C and A criteria). Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
THRM
- NASDAQ - AUTOMOTIVE - Auto Parts
Gentherm Inc
|
$33.85 |
+0.60
1.80%
|
$34.45
|
$34.64
|
-2.28% |
404,079 78.77%
|
513,000
|
Most Recent Note for THRM - 3/26/2014 12:50:17 PM
Perched at its 52-week high, extended from any sound base pattern after wedging higher since last noted with caution in the 3/18/14 mid-day report - "Reported earnings +167% on +23% sales revenues for the Dec '13 quarter. That marked its 4th consecutive quarterly comparison with earnings above the +25% minimum guideline (C criteria). Its annual earnings growth was not steady but did improve after a drastic downturn in FY '08 and '09 earnings (A criteria)."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
WSCI
- NASDAQ - ELECTRONICS - Diversified Electronics
W S I Industries Inc
|
$7.86 |
-0.09 -1.10%
|
$8.10
|
$8.15
|
-3.55% |
24,559 272.88%
|
9,000
|
Most Recent Note for WSCI - 3/26/2014 12:53:49 PM
Spiked to new 52-week highs with a spurt of 4 consecutive volume-driven gains. Reported strong sales and earnings increases for the Feb '14 quarter but fundamental concerns remain. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied. Last noted with caution in the 11/01/10 mid-day report - "Extended from any sound base pattern after recent gains with above average volume. It is not an institutional quality stock, so use caution. There are only 2.89 million shares outstanding. It has minuscule sales revenues and earnings, despite impressive percentage increases for the latest quarter ended August 31, 2010."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|